Bertolo, R, Antonelli, A, Bex, A, Anderson, C, Autorino, R, Barber, N, Badani, K, Barod, R, Bensalah, K, Bernhard, JC, Breda, A, Capitanio, U, Challacombe, B, Crivellaro, S, De Groote, R, Derweesh, I, Galfano, A, Harke, N, Kaouk, J, Kutikov, A, Maes, K, Minervini, A, Maresma, MCM, Montorsi, F, Porpiglia, F, Porter, J, Schiavina, R, Siemer, S, Simone, G, Touijer, K, Vaessen, C, Volpe, A, Wu, ZJ, Zondervan, P, Russo, P, Ribal, MJ, Mottrie, A. An International Delphi Consensus About Tumor Rupture During Robotic Partial Nephrectomy (Researching UnPredictable TUmor RupturE during Robotic Partial Nephrectomy-The RUPTURE Project). European Urology Open Science. 2025; 78DOI:10.1016/j.euros.2025.01.019. PMID:41040668. IF:4.500(Q1/2D).

Panebianco, V, Catalano, C, Sanguedolce, F, De Santis, M, Padhani, AR. ESR Bridges: next-generation imaging in prostate cancer-a multidisciplinary view. EUROPEAN RADIOLOGY. 2025; 35(8)DOI:10.1007/s00330-025-11354-1. PMID:39890618. IF:4.700(Q1/2D).

Wuernschimmel, C, Wenzel, M, Moschovas, MC, Dell'Oglio, P, Paciotti, M, Bravi, CA, De Groote, R, Di Maida, F, Piramide, F, Turri, F, Andras, I, Sorce, G, Liakos, N, Breda, A, Larcher, A. Current training landscape for novice robotic surgeons: an international investigative survey by the Junior-ERUS/Young academic urologists (YAU) robotics in urology working group. WORLD JOURNAL OF UROLOGY. 2025; 43(1)DOI:10.1007/s00345-025-05845-5. PMID:40748464. IF:2.900(Q2/3D).

Contieri, R, Guigui, A, Gondran-Tellier, B, Basile, G, Zattoni, F, Gallioli, A, Verri, P, Aumatell, J, Lechevallier, E, Bastide, C, Akiki, A, Toledano, H, Moschini, M, Amparore, D, Mertens, LS, Pradere, B, Rajwa, P, Teoh, JYC, Porpiglia, F, Breda, A, Montorsi, F, Baboudjian, M, Uleri, A. Key strategies for reducing recurrence in T1 bladder cancer. Evidence from a retrospective multicenter European study. INTERNATIONAL UROLOGY AND NEPHROLOGY. 2025; 57(8)DOI:10.1007/s11255-025-04416-2. PMID:39934553. IF:1.900(Q3/6D).

Shore, ND, Powles, TB, Bedke, J, Galsky, MD, Redorta, JP, Ku, JH, Kretkowski, M, Xylinas, E, Alekseev, B, Ye, DW, Guerrero-Ramos, F, Briganti, A, Kulkarni, GS, Brinkmann, J, Calella, AM, Cesari, R, Eccleston, A, Michelon, E, Vermette, J, Wei, CM, Steinberg, GD. Sasanlimab plus BCG in BCG-naive, high-risk non-muscle invasive bladder cancer: the randomized phase 3 CREST trial. NATURE MEDICINE. 2025; 31(8)DOI:10.1038/s41591-025-03738-z. PMID:40450141. IF:50.000(Q1/1D).

Scilipoti, P, Moschini, M, Zaurito, P, Longoni, M, De Angelis, M, Afferi, L, Lonati, C, Tremolada, G, Viti, A, Santangelo, A, Pichler, R, Necchi, A, Montorsi, F, Briganti, A, Mari, A, Krajewski, W, Laukthina, E, Pradere, B, Del Giudice, F, Mertens, L, Gallioli, A, Soria, F, Gontero, P, Albisinni, S, Shariat, SF, Carando, R. Prognostic Implications of Patients With Clinically Node Positive Bladder Cancer Undergoing Radical Cystectomy. Clinical Genitourinary Cancer. 2025; 23(4)DOI:10.1016/j.clgc.2025.102377. PMID:40514269. IF:2.700(Q2/3D).

Sanguedolce, F, Tedde, A, Basile, G, Di Bello, F, Baboudjian, M, Uleri, A, Mancon, S, Chernysheva, D, Figuls, MR, Gallioli, A, Territo, A, Rouprêt, M, Palou, J, Breda, A. Prostate Cancer Outcomes in Immunocompromised Patients: A Systematic Review and Meta-analysis. European Urology Oncology. 2025; 8(4)DOI:10.1016/j.euo.2025.05.021. PMID:40533295. IF:9.300(Q1/1D).

Shore, ND, Powles, TB, Bedke, J, Galsky, MD, Redorta, JP, Ku, JH, Kretkowski, M, Xylinas, E, Alekseev, B, Ye, DW, Guerrero-Ramos, F, Briganti, A, Kulkarni, GS, Brinkmann, J, Calella, AM, Cesari, R, Eccleston, A, Michelon, E, Vermette, J, Wei, CM, Steinberg, GD. Sasanlimab plus BCG in BCG-naive, high-risk non-muscle invasive bladder cancer: the randomized phase 3 CREST trial (May, 10.1038/s41591-025-03738-z, 2025). NATURE MEDICINE. 2025; 31(8)DOI:10.1038/s41591-025-03894-2. PMID:40691368. IF:50.000(Q1/1D).